EN
中文 EN
Company News
Home >Newsroom >Company News
ALL
2024
2023
2022
2021
2020
2019
2018
2016
2015
2014
2013
2012
2007
2022.12.27
First Overseas Shipment of CanSinoBIO’s Convidecia Air™ Delivered to Morocco
2022.11.17
CanSinoBIO Leads Sino-Indonesian Collaboration on Mucosal Vaccine Development
2022.11.10
CanSinoBIO’s Convidecia Air™ Approved for Emergency Use in Morocco
2022.11.10
CanSino Biologics and AstraZeneca Sign Strategic Collaboration Agreement to Deepen Research on Rare Diseases
2022.10.25
CanSino Biologics Celebrates the Rollout of the Inhaled Vaccine, Convidecia Air™, in Shanghai
2022.10.06
CanSinoBIO to Present Latest Data on Convidecia Air™ at the World Vaccine Congress Europe 2022
2022.09.04
CanSinoBIO's Convidecia Air™ Receives Approval in China
2022.08.18
Convidecia Air™ Receives Clinical Trial Approval in Malaysia
2022.05.20
COVID-19 Vaccine Convidecia™ Receives WHO Emergency Use Listing
2022.04.25
CanSinoBIO Rebrands to Reflect Commitment to Life Sciences Research
12